483 related articles for article (PubMed ID: 22007962)
21. Functionalization of nanodiamond with vitamin E TPGS to facilitate oral absorption of curcumin.
Cheng B; Pan H; Liu D; Li D; Li J; Yu S; Tan G; Pan W
Int J Pharm; 2018 Apr; 540(1-2):162-170. PubMed ID: 29452153
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
[TBL] [Abstract][Full Text] [Related]
23. Preparation and cytotoxicity of N-modified chitosan nanoparticles applied in curcumin delivery.
Facchi SP; Scariot DB; Bueno PV; Souza PR; Figueiredo LC; Follmann HD; Nunes CS; Monteiro JP; Bonafé EG; Nakamura CV; Muniz EC; Martins AF
Int J Biol Macromol; 2016 Jun; 87():237-45. PubMed ID: 26930578
[TBL] [Abstract][Full Text] [Related]
24. The Formation of Chitosan-Coated Rhamnolipid Liposomes Containing Curcumin: Stability and In Vitro Digestion.
Zhou W; Cheng C; Ma L; Zou L; Liu W; Li R; Cao Y; Liu Y; Ruan R; Li J
Molecules; 2021 Jan; 26(3):. PubMed ID: 33494543
[TBL] [Abstract][Full Text] [Related]
25. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo evaluation of curcumin loaded lauroyl sulphated chitosan for enhancing oral bioavailability.
Shelma R; Sharma CP
Carbohydr Polym; 2013 Jun; 95(1):441-8. PubMed ID: 23618291
[TBL] [Abstract][Full Text] [Related]
27. Liposomes coated with thiolated chitosan as drug carriers of curcumin.
Li R; Deng L; Cai Z; Zhang S; Wang K; Li L; Ding S; Zhou C
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():156-164. PubMed ID: 28866151
[TBL] [Abstract][Full Text] [Related]
28. Characterization of N-trimethyl chitosan/alginate complexes and curcumin release.
Martins AF; Bueno PV; Almeida EA; Rodrigues FH; Rubira AF; Muniz EC
Int J Biol Macromol; 2013 Jun; 57():174-84. PubMed ID: 23511054
[TBL] [Abstract][Full Text] [Related]
29. Comparison of different aliphatic acid grafted N-trimethyl chitosan surface-modified nanostructured lipid carriers for improved oral kaempferol delivery.
Du Q; Chen J; Yan G; Lyu F; Huang J; Ren J; Di L
Int J Pharm; 2019 Sep; 568():118506. PubMed ID: 31302169
[TBL] [Abstract][Full Text] [Related]
30. Curcumin-loaded PLGA-PEG-PLGA triblock copolymeric micelles: Preparation, pharmacokinetics and distribution in vivo.
Song Z; Feng R; Sun M; Guo C; Gao Y; Li L; Zhai G
J Colloid Interface Sci; 2011 Feb; 354(1):116-23. PubMed ID: 21044788
[TBL] [Abstract][Full Text] [Related]
31. Colon targeted curcumin microspheres laden with ascorbic acid for bioavailability enhancement.
Karade PG; Jadhav NR
J Microencapsul; 2018 Jun; 35(4):372-380. PubMed ID: 30010458
[TBL] [Abstract][Full Text] [Related]
32. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation.
Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D
Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620
[TBL] [Abstract][Full Text] [Related]
33. Trimethyl chitosan nanoparticles for ocular baicalein delivery: Preparation, optimization, in vitro evaluation, in vivo pharmacokinetic study and molecular dynamics simulation.
Li J; Jin X; Yang Y; Zhang L; Liu R; Li Z
Int J Biol Macromol; 2020 Aug; 156():749-761. PubMed ID: 32320806
[TBL] [Abstract][Full Text] [Related]
34. Enhanced systemic exposure of fexofenadine via the intranasal administration of chitosan-coated liposome.
Qiang F; Shin HJ; Lee BJ; Han HK
Int J Pharm; 2012 Jul; 430(1-2):161-6. PubMed ID: 22525082
[TBL] [Abstract][Full Text] [Related]
35. Development of chitosan-coated liposomes for sustained delivery of tamarind fruit pulp's extract to the skin.
Phetdee M; Polnok A; Viyoch J
Int J Cosmet Sci; 2008 Aug; 30(4):285-95. PubMed ID: 18713075
[TBL] [Abstract][Full Text] [Related]
36. pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation.
Sareen R; Jain N; Rajkumari A; Dhar KL
Drug Deliv; 2016; 23(1):55-62. PubMed ID: 24758141
[TBL] [Abstract][Full Text] [Related]
37. Galactosamine-modified PEG-PLA/TPGS micelles for the oral delivery of curcumin.
Sun S; Du X; Fu M; Khan AR; Ji J; Liu W; Zhai G
Int J Pharm; 2021 Feb; 595():120227. PubMed ID: 33484915
[TBL] [Abstract][Full Text] [Related]
38. Enhanced oral bioavailability and anticancer activity of novel curcumin loaded mixed micelles in human lung cancer cells.
Patil S; Choudhary B; Rathore A; Roy K; Mahadik K
Phytomedicine; 2015 Nov; 22(12):1103-11. PubMed ID: 26547533
[TBL] [Abstract][Full Text] [Related]
39. Potential advantages of a novel chitosan-N-acetylcysteine surface modified nanostructured lipid carrier on the performance of ophthalmic delivery of curcumin.
Liu D; Li J; Pan H; He F; Liu Z; Wu Q; Bai C; Yu S; Yang X
Sci Rep; 2016 Jun; 6():28796. PubMed ID: 27350323
[TBL] [Abstract][Full Text] [Related]
40. Tocophersolan stabilized lipid nanocapsules with high drug loading to improve the permeability and oral bioavailability of curcumin.
Bapat P; Ghadi R; Chaudhari D; Katiyar SS; Jain S
Int J Pharm; 2019 Apr; 560():219-227. PubMed ID: 30776407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
